GE HealthCare to Acquire SOFIE Biosciences, Establishing a ‘Final Mile’ Footprint for PET Radiopharmaceutical Supply in the U.S.

Broadens GE HealthCare’s footprint in the U.S. radiopharmaceutical industry, drives patient access to F18 labeled Positron Emission Tomography (PET) radiopharmaceuticals and enhances exposure to new high-growth areas Pharmaceutical Diagnostics (PDx) continues to partner with other established Contract Manufacturing Organizations (CMOs) to drive and expand patient access to its radiopharmaceutical portfolio, while SOFIE Biosciences continues to […]